F L

Generic Name: milnacipran

Pill imprint F L has been identified as Savella milnacipran 12.5 mg.

Savella is used in the treatment of fibromyalgia; reflex sympathetic dystrophy syndrome and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy.

Savella milnacipran 12.5 mg is not subject to the Controlled Substances Act.
See also related documents.

Savella Images

Generic Name:
milnacipran
Imprint:
F
L
Strength:
milnacipran 12.5 mg
Color:
Blue
Size:
5.00 mm
Shape:
Round
Availability:
Prescription only
Inactive Ingredients:
calcium phosphate dihydrate dibasic
povidone
carboxymethylcellulose calcium
silicon dioxide
magnesium stearate
magnesium silicate
FD&C Red No. 40
hypromelloses
polyethylene glycol
titanium dioxide
Drug Class:
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Forest Laboratories, Inc. and Cypress Bioscience, Inc.
National Drug Code (NDC):
00456-1512

Submitted by: Soundnerd

View Drug DetailsPrint Page

Savella milnacipran 12.5 mg F L
Advertisement

Savella is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web4)